These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 32643976
21. Sustained response to tocilizumab, anti-IL-6 antibody, following anti-TNF-α failure in a patient with relapsing polychondritis complicated by aortitis. Narshi CB, Allard SA. Rheumatology (Oxford); 2012 May; 51(5):952-3. PubMed ID: 22298790 [No Abstract] [Full Text] [Related]
22. Miscellaneous Ocular Symptoms in a Case of Relapsing Polychondritis. Fukuda K, Kishimoto T, Fukushima A. Ocul Immunol Inflamm; 2021 Feb 17; 29(2):352-354. PubMed ID: 31663794 [Abstract] [Full Text] [Related]
23. Not So Classic: An Unusual Presentation of a Rare Disease. Garg S, Lipson A. Arthritis Care Res (Hoboken); 2017 Jul 17; 69(7):1066-1068. PubMed ID: 27898992 [No Abstract] [Full Text] [Related]
24. Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis. Kawai M, Hagihara K, Hirano T, Shima Y, Kuwahara Y, Arimitsu J, Narazaki M, Ogata A, Kawase I, Kishimoto T, Tanaka T. Rheumatology (Oxford); 2009 Mar 17; 48(3):318-9. PubMed ID: 19106169 [No Abstract] [Full Text] [Related]
25. Relapsing polychondritis: response to tocilizumab and association with colitis. Plunkett M, Lamont D, Brooker J, White D. J Clin Rheumatol; 2013 Oct 17; 19(7):415-7. PubMed ID: 24048111 [No Abstract] [Full Text] [Related]
27. Rare within rare. Necrotising scleritis and peripheral ulcerative keratitis: eye-threatening complications of relapsing polychondritis. Damian L, Pamfil C, Bucșa C, Nicula C, Mouthon L, Amoura Z, Cutolo M, Burmester GR, Fonseca JE, Grapini L, Arnaud L, Rednic S. Clin Exp Rheumatol; 2022 May 17; 40 Suppl 134(5):86-92. PubMed ID: 35238768 [Abstract] [Full Text] [Related]
28. Cyclosporin A in the treatment of relapsing polychondritis with severe recurrent eye involvement. Priori R, Paroli MP, Luan FL, Abdulaziz M, Pivetti Pezzi P, Valesini G. Br J Rheumatol; 1993 Apr 17; 32(4):352. PubMed ID: 8461940 [No Abstract] [Full Text] [Related]
29. Efficacy of tocilizumab highlighted by FDG-PET/CT in a patient with relapsing polychondritis-associated aortitis. Elourimi G, Soussan M, Warzocha U, Bugaud H, Dhôte R, Abad S. Rheumatol Int; 2017 Nov 17; 37(11):1931-1935. PubMed ID: 28965131 [Abstract] [Full Text] [Related]
30. Tocilizumab in VEXAS relapsing polychondritis: a single-center pilot study in Japan. Kirino Y, Takase-Minegishi K, Tsuchida N, Hirahara L, Kunishita Y, Yoshimi R, Nakajima H. Ann Rheum Dis; 2021 Nov 17; 80(11):1501-1502. PubMed ID: 34260381 [No Abstract] [Full Text] [Related]
31. Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry. Vitale A, Caggiano V, Martin-Nares E, Frassi M, Dagna L, Hissaria P, Sfriso P, Hernández-Rodríguez J, Ruiz-Irastorza G, Monti S, Tufan A, Piga M, Giardini HAM, Lopalco G, Viapiana O, De Paulis A, Triggianese P, Vitetta R, de-la-Torre A, Fonollosa A, Caroni F, Sota J, Conticini E, Sbalchiero J, Renieri A, Casamassima G, Wiesik-Szewczyk E, Yildirim D, Hinojosa-Azaola A, Crisafulli F, Franceschini F, Campochiaro C, Tomelleri A, Callisto A, Beecher M, Bindoli S, Baggio C, Gómez-Caverzaschi V, Pelegrín L, Soto-Peleteiro A, Milanesi A, Vasi I, Cauli A, Antonelli IPB, Iannone F, Bixio R, Casa FD, Mormile I, Gurnari C, Fiorenza A, Mejia-Salgado G, Kawakami-Campos PA, Ragab G, Ciccia F, Ruscitti P, Bocchia M, Balistreri A, Tosi GM, Frediani B, Cantarini L, Fabiani C. Semin Arthritis Rheum; 2024 Jun 17; 66():152430. PubMed ID: 38554594 [Abstract] [Full Text] [Related]
32. Treatment of relapsing polychondritis with tocilizumab. Wendling D, Godfrin-Valnet M, Prati C. J Rheumatol; 2013 Jul 17; 40(7):1232. PubMed ID: 23818726 [No Abstract] [Full Text] [Related]
33. Ocular Inflammation as the First Sign of Relapsing Polychondritis in Hispanic Patients: Report of Three Cases. Villa-Piñeros J, Ramos-Santodomingo M, Rojas-Carabali W, de-la-Torre A. Ocul Immunol Inflamm; 2024 Feb 17; 32(2):244-249. PubMed ID: 36638347 [Abstract] [Full Text] [Related]
34. Efficacy of tocilizumab for refractory relapsing polychondritis with tracheal stenosis and respiratory distress. Liao HT. Rheumatology (Oxford); 2022 Mar 02; 61(3):1293-1294. PubMed ID: 33989404 [No Abstract] [Full Text] [Related]
35. Relapsing polychondritis. Chow MT, Anderson SF. Optom Vis Sci; 2000 Jun 02; 77(6):286-92. PubMed ID: 10879785 [Abstract] [Full Text] [Related]
36. Exacerbation of Ulcerative Colitis with Tocilizumab: A Report of Two Cases, One with Takayasu Arteritis and the Other with Relapsing Polychondritis. Hanioka Y, Shimizu K, Yamagami K, Yao S, Nakamura R, Nakamura T, Goto H. Intern Med; 2021 May 15; 60(10):1615-1620. PubMed ID: 33281154 [Abstract] [Full Text] [Related]
37. Biologics in relapsing polychondritis: a case series. Moulis G, Sailler L, Pugnet G, Astudillo L, Arlet P. Clin Exp Rheumatol; 2013 May 15; 31(6):937-9. PubMed ID: 24021708 [Abstract] [Full Text] [Related]
39. Sustained remission of pediatric relapsing polychondritis with adalimumab. Navarrete VM, Lebrón CV, de Miera FJ, Candau CP, Sarabia FN. J Clin Rheumatol; 2014 Jan 15; 20(1):45-6. PubMed ID: 24356482 [No Abstract] [Full Text] [Related]
40. Relapsing polychondritis: case report and review of the literature. Khan AJ, Lynfield Y, Baldwin H. Cutis; 1994 Aug 15; 54(2):98-100. PubMed ID: 7956342 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]